GSK and other drugmakers fending off litigation claiming that gastrointestinal drug Zantac or a generic caused cancer have won a supreme court ruling in Canada, after also chalking up wins in the US.

Shares in GSK fell around 9% this morning after ... of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial. Judge Vivian Medinilla of Delaware Superior Court issued an ...

Pharmaceutical giant GSK has won a potentially expensive personal injury case in the US over its heartburn medicine Zantac. Angela Valadez, an 89-year-old woman living in the state of Illinois ...

(Bloomberg) -- GSK Plc is facing a whistleblower ... cases in California involving claims Zantac caused users’ cancers. The accords came on the eve of trial in some cases. The whistleblower ...

Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc ... lawsuits to proceed to trial over claims that the heartburn drug Zantac is linked to cancer.

GSK was fully aware of the source of NDMA and had been for nearly 40 years before withdrawing Zantac from the market; (2) while Defendants asserted that "data published prior to 2019 claims ...

and Durham, N.C. The lawsuit says GSK lied to investors about Zantac’s safety. Yost said the drug was prescribed more than 15 million times a year since introduced in the United States in 1983.

GSK plc (NYSE:GSK) – GSK agreed to pay up to $2.2 billion to settle 93% of U.S. lawsuits related to Zantac, alleging the ... promising results from an early trial for its treatment of X-linked ...